Xiaojun Man

440 total citations
22 papers, 244 citations indexed

About

Xiaojun Man is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xiaojun Man has authored 22 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Xiaojun Man's work include Epigenetics and DNA Methylation (6 papers), Cancer-related molecular mechanisms research (5 papers) and Renal cell carcinoma treatment (4 papers). Xiaojun Man is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Cancer-related molecular mechanisms research (5 papers) and Renal cell carcinoma treatment (4 papers). Xiaojun Man collaborates with scholars based in China and Japan. Xiaojun Man's co-authors include Chuize Kong, Yuanjun Jiang, Xiaolu Cui, Chiyuan Piao, Xuyong Lin, Zhe Zhang, Yuyan Zhu, Zhipeng Gao, Zhenhua Li and Xiankui Liu and has published in prestigious journals such as Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, BMC Cancer and Cellular Signalling.

In The Last Decade

Xiaojun Man

18 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojun Man China 9 185 115 44 41 20 22 244
Jianjiao Lin China 8 173 0.9× 96 0.8× 51 1.2× 52 1.3× 22 1.1× 20 228
Hong Ren China 10 260 1.4× 162 1.4× 37 0.8× 59 1.4× 19 0.9× 17 309
Jiansheng Guo China 10 150 0.8× 127 1.1× 26 0.6× 57 1.4× 22 1.1× 19 251
Silvia Cruz-Gil Spain 6 225 1.2× 212 1.8× 51 1.2× 55 1.3× 19 0.9× 9 331
Dapeng Lei China 13 266 1.4× 199 1.7× 30 0.7× 50 1.2× 16 0.8× 33 309

Countries citing papers authored by Xiaojun Man

Since Specialization
Citations

This map shows the geographic impact of Xiaojun Man's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Man with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Man more than expected).

Fields of papers citing papers by Xiaojun Man

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Man. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Man. The network helps show where Xiaojun Man may publish in the future.

Co-authorship network of co-authors of Xiaojun Man

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojun Man. A scholar is included among the top collaborators of Xiaojun Man based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojun Man. Xiaojun Man is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Man, Xiaojun, et al.. (2025). Sacral Hemangioma Mimicking Bone Metastasis on 18F-PSMA-1007 PET/CT. Clinical Nuclear Medicine. 50(11). 1083–1086. 1 indexed citations
2.
Zhang, Hao, et al.. (2025). Methyltransferase-like 7B participates in bladder cancer via ACSL3 m6A modification in a ferroptosis manner. Biology Direct. 20(1). 9–9. 3 indexed citations
3.
Man, Xiaojun, Yan Zhang, Jiani He, Pingping Wang, & Wei Qu. (2025). From bench to bedside: Synthetic strategies and clinical application of PARP inhibitors. Bioorganic Chemistry. 163. 108761–108761. 2 indexed citations
4.
Man, Xiaojun, et al.. (2025). FDG PET/CT in Splenic Metastasis From Renal Cell Carcinoma. Clinical Nuclear Medicine. 50(12). 1209–1213.
5.
Man, Xiaojun, et al.. (2025). Intense FDG Activity of Renal Granuloma Following Intravesical Bacillus Calmette-Guérin Therapy for Bladder Cancer Mimicking Malignancy. Clinical Nuclear Medicine. 50(10). 960–962. 1 indexed citations
6.
Man, Xiaojun, et al.. (2025). Urethral Diverticulum Mimicking Metastatic Prostate Cancer on 68Ga-PSMA-11 PET/CT. Clinical Nuclear Medicine. 50(10). 941–942.
7.
Yuan, Ziyue, et al.. (2024). Targeting autophagy in urological system cancers: From underlying mechanisms to therapeutic implications. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6). 189196–189196. 2 indexed citations
8.
Li, Jianfeng, et al.. (2024). CircRNA LOC729852 promotes bladder cancer progression by regulating macrophage polarization and recruitment via the miR‐769‐5p/IL‐10 axis. Journal of Cellular and Molecular Medicine. 28(7). e18225–e18225. 10 indexed citations
9.
Liu, Shuangjie, Lei Dou, Miao Miao, et al.. (2023). HES1-mediated down-regulation of miR-138 sustains NOTCH1 activation and promotes proliferation and invasion in renal cell carcinoma. Journal of Experimental & Clinical Cancer Research. 42(1). 72–72. 8 indexed citations
10.
Man, Xiaojun, et al.. (2023). Phosphorylated MAPK11 promotes the progression of clear cell renal cell carcinoma by maintaining RUNX2 protein abundance. Journal of Cellular and Molecular Medicine. 27(17). 2583–2593. 7 indexed citations
11.
12.
Bao, Han, et al.. (2022). Factors affecting hemostasis in the control of iatrogenic renal hemorrhage. World Journal of Urology. 40(6). 1581–1586.
13.
Zhang, Hao, et al.. (2022). The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis. Cellular Signalling. 102. 110527–110527. 12 indexed citations
14.
Zhang, Hao, et al.. (2022). The LINC00852/miR-29a-3p/JARID2 axis regulates the proliferation and invasion of prostate cancer cell. BMC Cancer. 22(1). 1269–1269. 7 indexed citations
15.
Man, Xiaojun, Chiyuan Piao, Xuyong Lin, et al.. (2019). USP13 functions as a tumor suppressor by blocking the NF-kB-mediated PTEN downregulation in human bladder cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 259–259. 72 indexed citations
16.
Gao, Zhipeng, Xiaojun Man, Zhenhua Li, et al.. (2019). Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma. Oncology Reports. 41(4). 2440–2452. 7 indexed citations
17.
Man, Xiaojun, Yuanjun Jiang, Zhe Zhang, et al.. (2019). <p>Silencing of CARMA3 inhibits bladder cancer cell migration and invasion via deactivating β-catenin signaling pathway</p>. OncoTargets and Therapy. Volume 12. 6309–6322. 9 indexed citations
18.
Gao, Zhipeng, Xiaojun Man, Zhenhua Li, et al.. (2019). PLK1 promotes proliferation and suppresses apoptosis of renal cell carcinoma cells by phosphorylating MCM3. Cancer Gene Therapy. 27(6). 412–423. 35 indexed citations
19.
Zhang, Yixiao, Zhe Zhang, Zhenhua Li, et al.. (2016). MicroRNA-497 inhibits the proliferation, migration and invasion of human bladder transitional cell carcinoma cells by targeting E2F3. Oncology Reports. 36(3). 1293–1300. 28 indexed citations
20.
Man, Xiaojun, et al.. (2014). Clinical significance and biological roles of CARMA3 in human bladder carcinoma. Tumor Biology. 35(5). 4131–4136. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianjiao Lin Breakdown of academic impact, for papers by Hong Ren Breakdown of academic impact, for papers by Jiansheng Guo Breakdown of academic impact, for papers by Silvia Cruz-Gil Breakdown of academic impact, for papers by Dapeng Lei
Rankless by CCL
2026